Home > Healthcare > Medical Services > Surgical Services > Aesthetic Medicine Market

Aesthetic Medicine Market Size

  • Report ID: GMI2687
  • Published Date: May 2024
  • Report Format: PDF

Aesthetic Medicine Market Size

Aesthetic Medicine Market size was valued at around USD 19.2 billion in 2023 and is estimated to grow at 12% CAGR from 2024 to 2032. Aesthetic medicine, also known as cosmetic medicine, is a branch of medicine focused on enhancing a person's appearance through medical and cosmetic treatments.

 

Its primary aim is to improve cosmetic appearance through the treatment of conditions such as wrinkles, scars, excess fat, skin laxity, cellulite, unwanted hair, and skin discoloration. It encompasses a wide range of non-invasive, minimally invasive surgical instruments, and surgical procedures performed by trained medical professionals, including dermatologists, plastic surgeons, cosmetic surgeons, and other qualified practitioners.
 

The growing awareness of aesthetic procedures is significantly driving the aesthetic medicine market. As consumer knowledge increases about the benefits and effectiveness of these treatments, there's a rising demand for devices that support these procedures. For instance, in April 2023, the American Association of Plastic Surgeons held their 101st annual meeting in Chicago, demonstrating about the latest plastic surgery developments and network with other professionals in the field. As consumer knowledge increases about the benefits and effectiveness of these treatments, there's a rising demand for devices that support these procedures.
 

Furthermore, rising prevalence of obesity, increasing adoption of energy-based aesthetic devices, advancement in non-energy-based aesthetic devices, increasing facial implants, government initiatives and funding, and increasing education & awareness, are the promoting factors fostering the growth of the market.
 

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The aesthetic medicine market size was valued at USD 19.2 billion in 2023 and is estimated to grow at 12% CAGR from 2024 to 2032, driven by growing awareness of aesthetic procedures.

The non-surgical procedures type segment held decent share of the aesthetic medicine industry in 2023 and is estimated to account for USD 41.8 billion by 2032, as they are more affordable than surgical interventions.

U.S. aesthetic medicine market size is anticipated to grow at 11.4% CAGR during 2024 to 2032 owing to a large population with a significant demand for aesthetic procedures and treatments.

Apax Partners, Bausch Health Companies Inc, El.En. S.p.A., GC Aesthetics plc, Huadong Medicine Co., Ltd, Johnson & Johnson, Merz Pharma, Sciton, Inc., SharpLight Technologies Inc., and Sisram Medical Ltd among others.

Aesthetic Medicine Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 292
  • Countries covered: 22
  • Pages: 170
 Download Free Sample